International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. - Wikidata - awgldk - TriplyDB

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

http://www.wikidata.org/entity/Q45273212

about

Prevalence of chronic kidney disease in population-based studies: systematic review Interventions for improving health literacy in people with chronic kidney disease A new equation to estimate glomerular filtration rate Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review The Efficacy of Shen Shuaining Capsule on Chronic Kidney Disease: A Systematic Review and Meta-Analysis Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review Oral conditions in renal disorders and treatment considerations - A review for pediatric dentist Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis Developments in renal pharmacogenomics and applications in chronic kidney disease Chronic kidney disease: identification and management in primary care A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study The Association between Nutritional Markers and Biochemical Parameters and Residual Renal Function in Peritoneal Dialysis Patients Dialysis-treated end-stage kidney disease in Libya: epidemiology and risk factors.Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort.High prevalence of chronic kidney disease in Iran: a large population-based study.Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study Linking transcriptomic and proteomic data on the level of protein interaction networks.MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey.Soluble TNF receptors and kidney dysfunction in the elderly.Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.Prevalence of chronic kidney disease markers: Evidence from a three-million married population with fertility desire in rural China.Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study.Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study.Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort.Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.Relationship of diabetes with renal dysfunction in hypertensive adults.Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.Health-related quality of life and all-cause mortality in patients with diabetes on dialysis.Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES.Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease.

P2860

Q21257215-528EF48D-238B-4B65-BE82-81F0DDCD446A Q24186226-05FD4734-6D31-4384-84FD-ADFF1708D440 Q24651973-645854D1-C28E-42E7-B03E-60153B5BCBAF Q26744363-631E5B2A-167C-49EB-B230-C7FE74AFA4D8 Q26765271-ADE81585-C228-449D-ADD9-AA617BAADC70 Q26783181-460DE643-42A6-4DE1-93B6-163D9DE0A35E Q26799639-EA07115F-EB9C-4E11-AEE6-3CB02FC88633 Q26800105-E20AFD26-390D-403D-B7D7-FF4295E8F867 Q26827576-4A382272-E522-4AFC-AB32-98C03A8D8D21 Q26995926-FB1281B5-B956-4307-A1DF-4A93C18E85AC Q26999279-7BF84CF7-093B-419D-9BAC-0B2E04ED73EB Q28066936-89AC8232-6DFD-422A-8635-16D1E7417345 Q28484321-269F2DF2-7D1B-41E6-B469-3F5AC16A8B1C Q28541795-4946B25C-7552-4005-B76A-15AEFBDF2B88 Q28552675-CCA7BBDB-B8EC-4011-82AA-B3573119F2CA Q30360656-888AE7B6-79F5-4481-93A4-05D756E65E91 Q30407860-82F48054-4B74-44DB-9D22-FB1F3A92F240 Q30976231-978B82F3-8060-4F9C-BFF8-A305A176121C Q33404464-4E44980D-3058-4403-908A-7E5FCF507426 Q33503903-2E10F529-DECB-480E-AE34-0787A5BF63C2 Q33568802-C394AB0D-6F5C-437C-A515-577BCF1B8D8B Q33591792-B8B848BD-C55B-453F-B8DE-6F7DAE0650CF Q33612502-7A71F3E1-1286-4F95-B527-1B59A7057EA8 Q33660677-0C91E2D1-E174-4AE2-853A-4384739A54FD Q33721299-0E28DDBC-4B6A-4587-8719-7B274E6186D6 Q33756494-93DAE83F-F446-47A4-BFB0-FC7BB46D5AD1 Q33758820-2A48704F-8DAF-4E21-B706-779DABF624DB Q33776322-D4024A23-549F-4C2F-92DA-5967539B2C53 Q33801070-72771C39-CAD6-4BB5-ACB6-C136B783AEF7 Q33814870-F09C35B1-F8DF-453E-8361-C7B7C5076E69 Q33816875-204FE73A-9C20-4025-8F0F-C0E1CE62E863 Q33818145-1CACA2B4-6034-43B5-B407-9EC855A150F9 Q33838866-515ED5EB-D0F2-4EB6-8381-7026A629815B Q33932587-74B16DAD-E0D1-435F-A2AE-292D403D9E36 Q34039724-768720C8-7DEC-4CAC-BE4E-D689740200FF Q34122392-488F83A1-8612-4343-9945-9A501B8B877F Q34281450-1D8CB668-A1C2-48CB-A927-39F190F60A3A Q34366155-7430FB8A-5E8F-4FE9-9CD9-4FEA7D905F37 Q34405409-9A0D5471-EBDC-47FA-A558-6190339188AE Q34407904-F196F568-BC4B-4EE8-9ED9-55684ACAEF39

P2860

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

http://www.wikidata.org/entity/Q45273212

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

International comparison of th ...... ease prevalence and ESRD risk.

@en

International comparison of th ...... ease prevalence and ESRD risk.

@nl

type

label

International comparison of th ...... ease prevalence and ESRD risk.

@en

International comparison of th ...... ease prevalence and ESRD risk.

@nl

prefLabel

International comparison of th ...... ease prevalence and ESRD risk.

@en

International comparison of th ...... ease prevalence and ESRD risk.

@nl

P1433

Q45273212-2E84D54B-F51D-4AD6-9580-6C6CFCC5315B

P1476

Q45273212-B996417F-5DC9-42D1-9948-9D979F656B00

P2093

Q45273212-42BF6E11-C9E4-46BC-BB4E-219151DD8796

Q45273212-44CC447B-6FD9-4454-857A-7355F70CA2FB

Q45273212-98D8C9CC-6D97-4900-9375-144127A793EC

Q45273212-A124D408-3EAA-41DF-9BC9-AB9CDD5BA8E3

Q45273212-BB4F1CAD-4588-4E17-BF10-D5EDAE35184B

Q45273212-C3DDE566-2568-4A71-93EF-5EB003B70E78

Q45273212-F5A0B106-FFA3-4821-B9C8-FCCC10773D15

P304

Q45273212-42113422-43A8-4D49-9112-D06574C3D044

P31

Q45273212-10ED4B4E-05E9-4381-B98B-AB817D21EDB5

P356

Q45273212-E423004D-EA02-48F0-A4E6-506BF5D7AF2C

P433

Q45273212-05BF6BBA-C934-4BBA-B8F6-603FB396624B

P478

Q45273212-62C477D1-90DF-4924-B771-201CB89FF41E

P50

Q45273212-A22BBDDC-737B-4F5E-8984-BBB34DA93ACC

Q45273212-F1E7FCDF-D266-4A33-843A-A236D40656C8

P577

Q45273212-73182CB0-190D-41EC-B270-F993F64E6BC8

P698

Q45273212-40AAEBB4-CF06-4A3E-8BBA-45A0DFC7FC99

P356

P1433

Journal of the American Society of Nephrology

P1476

International comparison of th ...... ease prevalence and ESRD risk.

@en

P2093

Arne Asberg

http://www.w3.org/2001/XMLSchema#string

Brad C Astor

http://www.w3.org/2001/XMLSchema#string

Hans A Hallan

http://www.w3.org/2001/XMLSchema#string

Neil R Powe

http://www.w3.org/2001/XMLSchema#string

Solfrid Romundstad

http://www.w3.org/2001/XMLSchema#string

Stein I Hallan

http://www.w3.org/2001/XMLSchema#string

Stian Lydersen

http://www.w3.org/2001/XMLSchema#string

P304

2275-2284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2005121273

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16790511

http://www.w3.org/2001/XMLSchema#string